Effects of Standing on Glycemia in Prediabetic Adults
- Conditions
- Prediabetes
- Interventions
- Other: Sitting CGMOther: Sitting OGTTOther: Standing CGMOther: Standing OGTT
- Registration Number
- NCT01884792
- Lead Sponsor
- University of Minnesota
- Brief Summary
The study is a crossover, pilot trial examining the acute effects of standing on blood sugar in prediabetic, working adults. Participants will complete oral glucose tolerance testing, once while sitting and once while standing. They will also wear a continuous blood sugar monitor once while sitting at their desk for a week and once while using their desk as a sit-stand desk with a goal of standing intermittently for at least half of the work day. Physical activity levels will be measured with an accelerometer. The primary study hypothesis is that blood sugar will differ between the sitting and standing conditions for each of the tests performed.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- 20
- Fasting blood glucose >100 mg/dl
- Employed full-time working at least 35 hours/week
- Able to safely begin a light physical activity program
- Heart disease
- Renal disease
- Peripheral neuropathy
- Retinopathy
- PAD
- Lower limb amputation
- pregnancy
- active substance abuse
- current smoker
- psychiatric disorder
- severe visual impairment
- immune-compromised individuals,
- enrollment in a physical activity study
- use of insulin or an insulin pump
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- CROSSOVER
- Arm && Interventions
Group Intervention Description Standing Continuous Glucose Monitor Sitting CGM Participants are instructed to stand intermittently for at least half of their work day during this 5 day period. Blood sugar is monitored and physical activity is tracked with an accelerometer. Sitting Oral Glucose Tolerance Test Sitting OGTT An OGTT is performed while the subject sits at their desk for the entire 2-hour period. 5 blood sugar measurements are taken and a 75g dextrose beverage is consumed following the first, baseline blood sugar reading. The blood sugar is then measured every 30 minutes up to 120 min. Sitting Continuous Glucose Monitor Standing CGM A continuous blood glucose monitor is worn for 5 days while at work. In the sitting condition the participant only sits at their desk for the duration of the week. Blood sugar is monitored 4 times per day to calibrate the CGM and an accelerometer is worn to track physical activity. Sitting Oral Glucose Tolerance Test Standing OGTT An OGTT is performed while the subject sits at their desk for the entire 2-hour period. 5 blood sugar measurements are taken and a 75g dextrose beverage is consumed following the first, baseline blood sugar reading. The blood sugar is then measured every 30 minutes up to 120 min. Standing Oral Glucose Tolerance Test Sitting OGTT The participant stands at their desk for the duration of the 2-hour blood sugar test. The same procedure is performed as in the sitting condition. Standing Oral Glucose Tolerance Test Standing OGTT The participant stands at their desk for the duration of the 2-hour blood sugar test. The same procedure is performed as in the sitting condition. Sitting Continuous Glucose Monitor Sitting CGM A continuous blood glucose monitor is worn for 5 days while at work. In the sitting condition the participant only sits at their desk for the duration of the week. Blood sugar is monitored 4 times per day to calibrate the CGM and an accelerometer is worn to track physical activity. Standing Continuous Glucose Monitor Standing CGM Participants are instructed to stand intermittently for at least half of their work day during this 5 day period. Blood sugar is monitored and physical activity is tracked with an accelerometer.
- Primary Outcome Measures
Name Time Method Blood sugar area under the curve 2 hours The area under the curve following the 2 hour blood sugar tests.
- Secondary Outcome Measures
Name Time Method Accelerometer counts 4 hours and 2 5 day periods Accelerometer counts in the 4 testing conditions.
Trial Locations
- Locations (1)
Department of Human Services
🇺🇸St. Paul, Minnesota, United States